{
  "nodes": [
    {
      "id": "N1",
      "label": "Step 1",
      "customData": {
        "node_id": "A",
        "node_step_index": 0,
        "content": "68-year-old female presented in May 2024 with cough and headache.",
        "timestamp": "2024-05",
        "clinical_data": {
          "HPI": [
            {
              "summary": "68-year-old female presented with cough and headache.",
              "onset": "May 2024",
              "associated_symptoms": [
                "C0011118",
                "C0019058"
              ]
            }
          ]
        }
      },
      "custom_id": "graph_048_N0"
    },
    {
      "id": "N2",
      "label": "Step 2",
      "customData": {
        "node_id": "B",
        "node_step_index": 1,
        "content": "Biopsy of the right supraclavicular lymph node confirmed lung adenocarcinoma.",
        "timestamp": "2024-05",
        "clinical_data": {
          "diagnoses": [
            {
              "code": "C0242375",
              "label": "Lung adenocarcinoma",
              "status": "active",
              "onset_date": null
            }
          ],
          "procedures": [
            {
              "name": "Biopsy",
              "approach": "other",
              "date": null,
              "location": "Right supraclavicular lymph node",
              "performed_by": null,
              "outcome": null
            }
          ]
        }
      },
      "custom_id": "graph_048_N1"
    },
    {
      "id": "N3",
      "label": "Step 3",
      "customData": {
        "node_id": "C",
        "node_step_index": 2,
        "content": "Diagnosis: Advanced lung adenocarcinoma, stage T1cN3M1c IVb, with multiple brain metastases.",
        "timestamp": "2024-05",
        "clinical_data": {
          "diagnoses": [
            {
              "code": "C34",
              "label": "Lung cancer",
              "status": "active"
            },
            {
              "code": "C79.3",
              "label": "Secondary malignant neoplasm of brain and cerebral meninges",
              "status": "active"
            }
          ]
        }
      },
      "custom_id": "graph_048_N2"
    },
    {
      "id": "N4",
      "label": "Step 4",
      "customData": {
        "node_id": "D",
        "node_step_index": 3,
        "content": "Initial imaging (Figure 1A) showed multiple brain metastases, pulmonary lesions, and mediastinal lymphadenopathy before treatment. Patient reported headaches and experienced sleep disturbances.",
        "timestamp": "2024-05",
        "clinical_data": {
          "imaging": [
            {
              "type": "brain metastases",
              "body_part": "brain",
              "modality": "imaging",
              "finding": "multiple",
              "date": null
            },
            {
              "type": "pulmonary lesions",
              "body_part": "lung",
              "modality": "imaging",
              "finding": null,
              "date": null
            },
            {
              "type": "mediastinal lymphadenopathy",
              "body_part": "mediastinum",
              "modality": "imaging",
              "finding": null,
              "date": null
            }
          ],
          "HPI": [
            {
              "summary": "Patient reported headaches and experienced sleep disturbances.",
              "associated_symptoms": [
                "headaches",
                "sleep disturbances"
              ]
            }
          ]
        }
      },
      "custom_id": "graph_048_N3"
    },
    {
      "id": "N5",
      "label": "Step 5",
      "customData": {
        "node_id": "E",
        "node_step_index": 4,
        "content": "Patient underwent whole-brain radiotherapy.",
        "clinical_data": {
          "procedures": [
            {
              "name": "Whole brain radiation therapy",
              "approach": "other",
              "date": null,
              "location": "brain",
              "performed_by": null,
              "outcome": null
            }
          ]
        }
      },
      "custom_id": "graph_048_N4"
    },
    {
      "id": "N6",
      "label": "Step 6",
      "customData": {
        "node_id": "F",
        "node_step_index": 5,
        "content": "NGS detected an IGR (downstream MAN1A1) ROS1:exon34 fusion at a mutant allele frequency (MAF) of 12.73%, accompanied by two TP53 mutations c.1024C>T (p.R342*) and c.686_687del (p.C229Yfs*10). RNA-seq identified a CD74:exon6 ~ ROS1: exon 35 fusion. Patient started first-line therapy with entrectinib (600 mg, once daily).",
        "clinical_data": {
          "labs": [
            {
              "test": "ROS1 gene fusion",
              "value": "12.73%",
              "unit": "MAF",
              "flag": "abnormal"
            }
          ],
          "diagnoses": [
            {
              "code": "ROS1",
              "label": "ROS1 fusion",
              "status": "active"
            },
            {
              "code": "TP53",
              "label": "TP53 mutation",
              "status": "active"
            }
          ],
          "medications": [
            {
              "drug": "Entrectinib",
              "dosage": "600 mg",
              "frequency": "once daily",
              "modality": "oral",
              "start_date": null,
              "end_date": null
            }
          ]
        }
      },
      "custom_id": "graph_048_N5"
    },
    {
      "id": "N7",
      "label": "Step 7",
      "customData": {
        "node_id": "G",
        "node_step_index": 6,
        "content": "Patient experienced significant improvements in headache and insomnia symptoms one month after entrectinib initiation. One month after entrectinib initiation, imaging showed the longest diameter of the left upper lung nodule decreased from 19 mm to 12 mm, and there was a notable reduction in the right hilar and mediastinal lymph nodes. Intracranial metastatic lesion reduced in size from 19 mm to 8 mm, with partial response (PR) to entrectinib treatment (Figure 1B).",
        "clinical_data": {
          "medications": [
            {
              "drug": "C1705477",
              "indication": "C0018793"
            }
          ],
          "imaging": [
            {
              "type": "C0024142",
              "body_part": "C0239155",
              "modality": "CT",
              "finding": "reduction in size",
              "date": null
            },
            {
              "type": "C0024142",
              "body_part": "C0226539",
              "modality": "CT",
              "finding": "reduction in size",
              "date": null
            },
            {
              "type": "C0026767",
              "body_part": "C0344454",
              "modality": "MRI",
              "finding": "reduction in size",
              "date": null
            }
          ],
          "HPI": [
            {
              "alleviating_factors": [
                "C1705477"
              ]
            }
          ]
        }
      },
      "custom_id": "graph_048_N6"
    },
    {
      "id": "N8",
      "label": "Step 8",
      "customData": {
        "node_id": "H",
        "node_step_index": 7,
        "content": "Five months on entrectinib: both the lung and brain lesions have consistently remained in a state of partial response. Patient experienced grade 2 blurred vision and oral mucositis",
        "CD74": "exon",
        "clinical_data": {
          "medications": [
            {
              "drug": "C1444755",
              "indication": "Lung cancer",
              "status": "active"
            }
          ],
          "diagnoses": [
            {
              "code": "C0024117",
              "label": "Lung cancer",
              "status": "active"
            }
          ],
          "ROS": [
            {
              "system": "neuro",
              "findings": [
                "blurred vision"
              ]
            }
          ],
          "HPI": [
            {
              "associated_symptoms": [
                "blurred vision",
                "oral mucositis"
              ]
            }
          ]
        }
      },
      "custom_id": "graph_048_N7"
    }
  ],
  "edges": [
    {
      "from": "N1",
      "to": "N2",
      "data": {
        "edge_id": "A_to_B",
        "branch_flag": true,
        "content": "Patient went for biopsy of right supraclavicular lymph node."
      },
      "custom_id": "graph_048_N1_N2"
    },
    {
      "from": "N2",
      "to": "N3",
      "data": {
        "edge_id": "B_to_C",
        "branch_flag": true,
        "content": "Diagnosis of advanced lung adenocarcinoma with multiple brain metastases was made."
      },
      "custom_id": "graph_048_N2_N3"
    },
    {
      "from": "N3",
      "to": "N4",
      "data": {
        "edge_id": "C_to_D",
        "branch_flag": true,
        "content": "Initial imaging revealed multiple brain metastases, pulmonary lesions, and mediastinal lymphadenopathy. Patient reported headaches and sleep disturbances."
      },
      "custom_id": "graph_048_N3_N4"
    },
    {
      "from": "N4",
      "to": "N5",
      "data": {
        "edge_id": "D_to_E",
        "branch_flag": true,
        "content": "Patient underwent whole-brain radiotherapy.",
        "transition_event": {
          "trigger_type": "procedure",
          "trigger_entities": [],
          "change_type": "addition",
          "target_domain": "procedure"
        }
      },
      "custom_id": "graph_048_N4_N5"
    },
    {
      "from": "N5",
      "to": "N6",
      "data": {
        "edge_id": "E_to_F",
        "branch_flag": true,
        "content": "NGS detected ROS1 fusion and TP53 mutations. Patient started entrectinib therapy.",
        "transition_event": {
          "trigger_type": "medication_change",
          "trigger_entities": [
            "C0000000"
          ],
          "change_type": "addition",
          "target_domain": "medication"
        }
      },
      "custom_id": "graph_048_N5_N6"
    },
    {
      "from": "N6",
      "to": "N7",
      "data": {
        "edge_id": "F_to_G",
        "branch_flag": true,
        "content": "Patient experienced improvements in headache and insomnia. Imaging showed a reduction in lung nodule size, mediastinal lymph nodes, and intracranial metastatic lesion size, indicating a partial response to entrectinib.",
        "transition_event": {
          "trigger_type": "symptom_onset",
          "trigger_entities": [
            "C0011118",
            "C0020551"
          ],
          "change_type": "resolution",
          "target_domain": "symptom"
        }
      },
      "custom_id": "graph_048_N6_N7"
    },
    {
      "from": "N7",
      "to": "N8",
      "data": {
        "edge_id": "G_to_H",
        "branch_flag": true,
        "content": "Lung and brain lesions remained in partial response. Patient experienced grade 2 blurred vision and oral mucositis.",
        "transition_event": {
          "trigger_type": "symptom_onset",
          "trigger_entities": [
            "C0005341",
            "C0026520"
          ],
          "change_type": "addition",
          "target_domain": "symptom"
        }
      },
      "custom_id": "graph_048_N7_N8"
    }
  ]
}